SCHEMBL4169934

SCHEMBL4169934

Fc1cccc([Mg]Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8042334 0.98 ACHE (0.41)
Bromide SCHEMBL1022118 0.98 ACHE (0.41)
SCHEMBL20184788 0.75
SCHEMBL37679 0.75
SCHEMBL31693851 0.75
Iodide SCHEMBL1864364 0.73 ACHE (0.41)
SCHEMBL28311260 0.73 NFE2L2 (0.45)
SCHEMBL14763721 0.73 CA12 (0.38)
SCHEMBL1157014 0.72
SCHEMBL29579005 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9534001-B2 Organomagnesium synthesis agent CHEMETALL GMBH (DE) 2017-01-03 US claimed
US-12180211-B2 Compounds, compositions and methods DENALI THERAPEUTICS INC. (US) 2024-12-31 US disclosed
EP-3746451-B1 BENZYL-, (PYRIDIN-3-YL)METHYL- OR (PYRIDIN-4-YL)METHYL-SUBSTITUTED OXADIAZOLOPYRIDINE DERIVATIVES AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2023-07-12 EP disclosed
CN-110383066-B Compounds, compositions and methods 戴纳立制药公司 2023-03-31 CN disclosed
EP-3552017-B1 COMPOUNDS USEFUL AS RIPK1 INHIBITORS DENALI THERAPEUTICS INC (US) 2022-02-23 EP disclosed
US-11254688-B2 Benzyl-, (pyridin-3-yl)methyl -or (pyridin-4-yl)-methyl-substituted oxadiazolopyridine derivatives as ghrelin O-acyl transferase (GOAT) inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-02-22 US disclosed
US-20210332058-A1 Compounds, Compositions and Methods DENALI THERAPEUTICS INC. (US) 2021-10-28 US disclosed
US-11072618-B2 Compounds, compositions and methods DENALI THERAPEUTICS INC. (US) 2021-07-27 US disclosed
US-20210053985-A1 BENZYL-, (PYRIDIN-3-YL)METHYL -OR (PYRIDIN-4-YL)-METHYL-SUBSTIITUTED OXADIAZOLOPYRIDINE DERIVATIVES AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-02-25 US disclosed
EP-3746451-A1 BENZYL-, (PYRIDIN-3-YL)METHYL- OR (PYRIDIN-4-YL)METHYL-SUBSTITUTED OXADIAZOLOPYRIDINE DERIVATIVES AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS Boehringer Ingelheim International GmbH (DE) 2020-12-09 EP disclosed
WO-2018107060-A1 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2018-06-14 WO disclosed
EP-3327002-A1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR Wako Pure Chemical Industries, Ltd. (JP) 2018-05-30 EP disclosed
CN-107278205-A Substituted nucleoside derivates as anticarcinogen 辉瑞大药厂 2017-10-20 CN disclosed
US-9534001-B2 Organomagnesium synthesis agent CHEMETALL GMBH (DE) 2017-01-03 US disclosed
US-7601734-B2 Such as methyl 5-(3,4-dihydro[1]benzofuro[3,2-c]pyridine-2(1H)-yl)-2,2-bis(4-fluorophenyl)pentanoate, having potent inhibitory effect on binding of alpha 2C-adrenoceptor; depression, anxiety, schizophrenia TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-10-13 US disclosed
US-20090173914-A1 ORGANOMAGNESIUM SYNTHESIS AGENT CHEMETALL GMBH (DE) 2009-07-09 US disclosed
EP-1994037-A1 ORGANOMAGNESIUM SYNTHESIS AGENT Chemetall GmbH (DE) 2008-11-26 EP disclosed
US-20070244145-A1 Cyclic Amine Compound TAISHO PHARMACEUTICAL CO., LTD. (JP) 2007-10-18 US disclosed
WO-2007099173-A1 ORGANOMAGNESIUM SYNTHESIS AGENT CHEMETALL GMBH (DE) 2007-09-07 WO disclosed
EP-1757605-A1 CYCLIC AMINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2007-02-28 EP disclosed